Carcinoma of Unknown Primary — Trials

Carcinoma of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,235 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,156
Recruiting: 2,259
Ph III recruiting: 267
Growth YoY: +12.6%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,895)

clinicaltrialsPublishedShowing 2,001–2,050 of 2,783 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06258642	Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC	recruiting	N/A	39	Fudan UniversityOTHER	1	Aug 20, 2025	clinicaltrials
NCT07131566	Immune Response in Cervical Lymph Nodes of Patients With Head and Neck Cancer	recruiting	—	500	Lars Olaf CardellOTHER	1	Aug 20, 2025	clinicaltrials
NCT07129512